Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate

Slični predmeti

• Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.
  od: Clerico, M, i dr.
  Izdano: (2008)
• Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.
  od: Clerico, M, i dr.
  Izdano: (2008)
• Recombinant interferon-beta efficacy in preventing conversion of clinically isolated syndromes to clinically defined multiple sclerosis: a Cochrane meta-analysis
  od: Clerico, M, i dr.
  Izdano: (2006)
• Early treatment to prevent conversion of clinically isolated syndrome to clinically defined multiple sclerosis: a Cochrane metanalysis
  od: Clerico, M, i dr.
  Izdano: (2008)
• Conversion from clinically isolated syndromes to multiple sclerosis: how could we prevent it? A Cochrane review of published trials
  od: Clerico, M, i dr.
  Izdano: (2007)